In this week’s Homerun Slides, we look at SGLT2 Inhibition as a novel treatment strategy for Type 2 Diabetes.
To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 9
Catch up on past Homerun Slides for The Present and Future of Insulin Therapy series.
To download part 8, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 8
To download part 7, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 7
To download part 6, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 6
To download part 5, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 5
To download part 4 and for links to parts 1 through 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 4
To download part 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 3
To download part 2, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 2
To download part 1, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 1
See more SGLT-2 Resources
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.